Male Breast Cancer: Understanding the Biology for Improved Patient Care
- Conditions
- Breast Cancer
- Registration Number
- NCT01101425
- Brief Summary
Rationale: Gathering medical information and tumor samples from patients with male breast cancer may help doctors learn more about the disease.
Purpose retrospective part: to perform a large international retrospective analysis of clinical and biological data of male BC patients treated in the participating centers from 1990 to 2010.
Purpose prospective part: to create a registry of men with breast cancer for a period of 30 months (starting early 2014).
- Detailed Description
Objectives retrospective part (closed to patients registration in September 2013):
* To perform a large international joint retrospective analysis of clinical and biological data of male breast cancer (BC) patients treated from 1990 to 2010.
* To create a database of patient characteristics, disease features, treatments received, and clinical outcomes of a large series of men diagnosed with BC from 1990 to 2010 in centers in Europe and USA.
* To perform a central pathological review of the corresponding large series of male BC tumors to determine their biologic characteristics and identify relevant prognostic and predictive markers.
Objectives prospective part (opened early 2014):
* To run a prospective registry of all male BC patients (including newly diagnosed) irrespective of the stage and treatment, in the participating institutions for a period of 30 months; collection of FFPE, fresh frozen and blood samples is optional but highly encouraged.
* Quality of Life sub-study
The two parts of this study will provide important information regarding male BC biology and clinical evolution. The collected follow-up information will provide an overview of the current practice in the early and the advanced disease and also offer precious information of the disease evolution in such rare patients' population.
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- Male
- Target Recruitment
- 200
Not provided
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical outcomes: survival, progression free survival, time to locoregional relapse, time to distant relapse, time to second primary. end of study Biological characterization of the disease End of study Patient and disease characteristics. end of study Patterns of treatment offered to these patients end of study
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (93)
Thermi Clinic
๐ฌ๐ทThessaloniki, Greece
Leighton Hospital
๐ฌ๐งCrewe, United Kingdom
Worthing Hospital
๐ฌ๐งWorthing, West Sussex, United Kingdom
ZNA Jan Palfijn
๐ง๐ชMerksem, Belgium
ZNA Middelheim
๐ง๐ชAntwerpen, Belgium
Hygeia Hospital
๐ฌ๐ทAthens, Greece
Agioi Anargiroi Hospital
๐ฌ๐ทKifisiรก, Greece
Mater Misericordia Hospital
๐ฎ๐ชDublin, Ireland
Waterford Regional Hospital
๐ฎ๐ชWaterford, Ireland
Hopital De Jolimont
๐ง๐ชHaine St Paul, Belgium
Beatson West of Scotland Cancer Centre
๐ฌ๐งGlasgow, United Kingdom
Crosshouse Hospital
๐ฌ๐งKilmarnock, United Kingdom
Instituto De Enfermedades Neoplasicas
๐ต๐ชLima, Peru
Queen Margaret Hospital
๐ฌ๐งDunfermline, United Kingdom
Hospital Universitario 12 De Octubre
๐ช๐ธMadrid, Spain
Spitalzentrum Biel
๐จ๐ญBiel, Switzerland
Centre Hospitalier Universitaire Vaudois
๐จ๐ญLausanne, Switzerland
City Hospital
๐ฌ๐งBirmingham, United Kingdom
Royal Sussex County Hospital
๐ฌ๐งBrighton, United Kingdom
Eastbourne District General Hospital
๐ฌ๐งEastbourne, United Kingdom
LLandough Hospital
๐ฌ๐งCardiff, United Kingdom
Cheltenham General Hospital
๐ฌ๐งCheltenham, United Kingdom
Royal Alexandra Hospital
๐ฌ๐งPaisley, United Kingdom
The Great Western Hospital
๐ฌ๐งSwindon, United Kingdom
Wishaw General Hospital
๐ฌ๐งWishaw, United Kingdom
Georgetown Lombardi Comprehensive Cancer Center
๐บ๐ธWashington, District of Columbia, United States
Cliniques Universitaires Saint-Luc
๐ง๐ชBrussels, Belgium
Aretaieio Hospital
๐ฌ๐ทAthens, Greece
IASO general hospital
๐ฌ๐ทAthens, Greece
Beaumont Hospital
๐ฎ๐ชDublin, Ireland
Cantonal Hospital Liestal
๐จ๐ญLiestal, Switzerland
ZeTuP St.Gallen
๐จ๐ญSt Gallen, Switzerland
Sonnenhofklinik Engeriedspital
๐จ๐ญBern, Switzerland
Luzerner Kantonsspital
๐จ๐ญLuzern, Switzerland
Hopital de Sion
๐จ๐ญSion, Switzerland
Kantonsspital Winterthur
๐จ๐ญWinterthur, Switzerland
Memorial Sloan-Kettering Cancer Center - Memorial hospital
๐บ๐ธNew York, New York, United States
Centro de Pesquisas Clinicas em Oncologia
๐ง๐ทPorto Alegre, Brazil
Cork University Hospital
๐ฎ๐ชCork, Ireland
St. Vincent'S Hospital
๐ฎ๐ชDublin, Ireland
Hospital General Vall D'Hebron
๐ช๐ธBarcelona, Spain
Kantonales Spital Herisau
๐จ๐ญHerisau, Switzerland
Kantonsspital St Gallen
๐จ๐ญSt Gallen, Switzerland
Western General Hospital
๐ฌ๐งEdinburgh, United Kingdom
Forth Valley Royal Hospital
๐ฌ๐งLarbert, United Kingdom
University Hospital of North Tees
๐ฌ๐งStockton on Tees, United Kingdom
Swedish Association of Breast Oncologists
๐ธ๐ชGรถteborg, Sweden
University Of Alabama Comprehensive Cancer Center
๐บ๐ธBirmingham, Alabama, United States
University Of Alabama Comprehensive Cancer Cente
๐บ๐ธBirmingham, Alabama, United States
UCSF University of California San Francisco Medical Center-Mount Zion
๐บ๐ธSan Francisco, California, United States
University of Chicago Medicine
๐บ๐ธChicago, Illinois, United States
Indiana University Medical Center
๐บ๐ธIndianapolis, Indiana, United States
Johns Hopkins University CRB1
๐บ๐ธBaltimore, Maryland, United States
Johns Hopkins University
๐บ๐ธBaltimore, Maryland, United States
Dana-Farber Cancer Institute
๐บ๐ธBoston, Massachusetts, United States
Mayo Clinic
๐บ๐ธRochester, Minnesota, United States
Duke University Medical Center
๐บ๐ธDurham, North Carolina, United States
Baylor college of Medicine
๐บ๐ธHouston, Texas, United States
MD Anderson Cancer Center
๐บ๐ธHouston, Texas, United States
Baylor College - Ucop
๐บ๐ธHouston, Texas, United States
Fred Hutchison Seattle Cancer Care Alliance
๐บ๐ธSeattle, Washington, United States
New Victoria Hospital
๐ฌ๐งGlasgow, United Kingdom
Champalimaud Cancer Center
๐ต๐นLisbon, Portugal
Universitair Ziekenhuis Antwerpen
๐ง๐ชEdegem, Belgium
University of Michigan
๐บ๐ธAnn Arbor, Michigan, United States
Kantonsspital Baden
๐จ๐ญBaden, Switzerland
Universitaetsspital Basel
๐จ๐ญBasel, Switzerland
Ospedale Beata Vergine
๐จ๐ญMendrisio, Switzerland
Cliniques Universitaires St. Luc
๐ง๐ชBrussels, Belgium
AZ Damiaan - Campus Sint-Jozef
๐ง๐ชOostende, Belgium
Alexandra Hospital
๐ฌ๐ทAthens, Greece
General Hospital of Air Force
๐ฌ๐ทAthens, Greece
General University Hospital Papageorgiou
๐ฌ๐ทThessaloniki, Greece
BOOG
๐ณ๐ฑAmsterdam, Netherlands
Hippokration General Hospital Of Athens
๐ฌ๐ทAthens, Greece
University General Hospital Heraklion
๐ฌ๐ทHeraklion, Greece
Medical University Of Gdansk
๐ต๐ฑGdansk, Poland
Maria Sklodowska-Curie Memorial Cancer Centre
๐ต๐ฑWarsaw, Poland
Institute of Oncology and Radiology
๐ท๐ธBelgrade, Serbia
Inselspital
๐จ๐ญBern, Switzerland
UniversitaetsSpital Zurich
๐จ๐ญZurich, Switzerland
Ain Shams University Hospital
๐ช๐ฌCairo, Egypt
CHU St Pierre
๐ง๐ชBrussels, Belgium
Hopital Universitaire Brugmann
๐ง๐ชBrussels, Belgium
Institut Jules Bordet
๐ง๐ชBrussels, Belgium
UZ Leuven
๐ง๐ชLeuven, Belgium
CHU Ucl Namu - Clinique Sainte Elisabeth
๐ง๐ชNamur, Belgium
Centro Regional Integrado de Oncologia
๐ง๐ทFortaleza, Brazil
St. James'S Hospital
๐ฎ๐ชDublin, Ireland
Instituto Nacional De Cancerologia
๐ฒ๐ฝMexico, Mexico
Instituto Portugues De Oncologia - Centro Do Porto
๐ต๐นPorto, Portugal
Radio-Onkologie Berner Oberland AG
๐จ๐ญThun, Switzerland
Royal Liverpool University Hospital
๐ฌ๐งLiverpool, United Kingdom